Heather Raymon serves as Executive at Artiva Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Heather Raymon has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 12, 2025 involved receiving (via award) 67,253 shares valued at $0.
Heather Raymon currently holds 106,844 shares of Artiva Biotherapeutics, Inc. (ARTV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Heather Raymon has been a net neutral trader of ARTV stock. They have purchased $0 and sold $0 worth of shares.
Heather Raymon's most recent insider trade was on Dec 12, 2025, when they sold 67,253 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.25 |
| Discretionary |
| Aug 15, 2025 | ARTV | $4.5K | Payment | 1,639 | $2.75 | Discretionary |
| May 15, 2025 | ARTV | $1.6K | Payment | 745 | $2.13 | Discretionary |
| Sep 12, 2024 | ARTV | $0 | Award | 10,000 | $N/A | Discretionary |